Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
PHARGR
Phoenix PIB Dutch Finance BV€400
1EMEA
Jul 29, 2020
currency
EUR
size (m)
400.000
maturity
Aug 5, 2025
type
Fixed
tenor
5.000
call
NCL
registration
Reg S Only
benchmark
-
ranking
-
moody's
NR
s&p
BB+
fitch
-
size description
-
re-open/tap
No
ipt
2.75% area
ipt-pxd
-
guidance
2.50% area
spread
321.2
coupon
2.375%
spread set
-
price
99.41900
yield
2.500%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
Registration: Reg S Only;
Relative Value

07/29/2020 PHOENIX PIB Dutch Finance BV (Phoenix Pharma) (PHARGR) EUR400m (up from EUR300m) Reg S sr notes due Aug 05, 2025 (5y). NCL (3mo par call, clean-up call). NR/BB+ (--/negative). Gtd by PHOENIX Pharmahandel GmbH & Co KG / PHOENIX International Beteiligungs GmbH. Via CA/Commerz/ING/UniCredit (B&D) joint books (ING coordinated logistics). List Lux. German law. Annual pay (Act/Act). 100x100. Settles 08/05 (T+5). ISIN: XS2212959352. Relevant stabilization regulations including FCA/ICMA will apply. Investor feedback was in the 2.50%-3.00% range. IPT: 2.75% area. Px talk: 2.50% area. Final terms: EUR400m 2.375% coupon to yield 2.50%. Priced: 2.375% at 99.419, yield 2.50%. +321.2bp vs OBL 0% 04/11/25. MS+288bp. Did investor call on 27 July at 10:30am UKT and a series of one-on-one and small group fixed income investor calls July 27-28. Books went subject at 12pm UKT 07/29. Book size greater than EUR815m (pre rec) at IPT, greater than EUR740m (pre rec) at guidance. Final book around EUR690m. UOP: GCP including. refinancing of existing Phoenix Pharma Group debt. Biz: a leading integrated healthcare provider in Europe operating in Pharmaceutical Wholesale, Pharmaceutical Retail and Pharma Services. HQ: Mannheim, Germany.

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.